COVID-19 – Wellcome Sanger Institute Blog

Covid Connections – Variant or Villain

June 29, 2021July 5, 2021 lolivaresboldu coronavirus, COVID-19, delta, genomic surveillance, mutations, sequencing, variant, virus min read

The second COVID connections talk brought together experts from COG-UK to discuss SARS-CoV-2 variants.

COVID-19

Genomics in a pandemic – Shedding light on the invisible

May 27, 2021July 3, 2021 lolivaresboldu coronavirus, COVID-19, genomic surveillance, public engagement, variants min read

Experts from the COVID-19 Genomics UK Consortium discuss sequencing SARS-CoV-2, variants, and viral fitness landscapes.

COVID-19 Sanger Life

Car manufacturing, cellular biology and COVID

May 18, 2021May 27, 2021 Sanger Institute COVID-19, management, stem cells min read

Rachel Nelson, head of the Cellular Generation and Phenotyping (CGaP) facility, reflects on managing science at scale, including the lessons from industries as far apart as car manufacturing and Silicon Valley.

Human Cell Atlas

Championing Team Science

April 30, 2021May 18, 2021 Sanger Institute COVID-19, Human Cell Atlas, research min read

Professor Muzlifah Haniffa shares her thoughts achieving large-scale science.

COVID-19 Sanger Life

Fighting Pathogens with Data and Partnerships

March 29, 2021May 27, 2021 Sanger Institute coronavirus, COVID-19, genomic surveillance, malaria min read

“Data analysis in genomics means that you can work in something that is meaningful.”

COVID-19 Sanger Life

Looking Down a Microscope and Seeing Discoveries Happen

January 25, 2021May 27, 2021 cc13sangeracuk cancer, COVID-19, covid19, malaria, meet the scientists, phd min read

Andy Russell is a PhD Student in the Voet, Lawniczak, and Billker groups at the Sanger Institute, studying cancer and malaria. He recently completed his PhD and will graduate this summer.

COVID-19 Sanger Science

20 Things We Learned in 2020

December 21, 2020May 27, 2021 cc13sangeracuk 2020, antibiotic resistance, artificial intelligence, blood disease, brain, brain cancer, cancer, cancer genetics, clones, collaboration, coronavirus, COVID-19, covid19, crohns disease, dantu, dengue, genomes, Genomics, glioblastoma, gut, heart, ibd, immune cells, immune system, malaria, mosquito, mosquitoes, near east, neglected tropical disease, pandemic, pathogen, pathogens, personalised medicine, plasmids, rare disease, rare genetic conditions, scallops, smoking, zika min read

This has been a year that none of us will forget in a hurry. The Institute is immensely proud of the way our staff have pulled together, and the work we have managed to achieve

COVID-19 Sanger Science

Sequencing COVID – what now?

November 3, 2020December 4, 2020 Sanger Institute coronavirus, COVID-19, disease surveillance, epidemiology, Sars-Cov-2, sequencing min read

Helping to track coronavirus outbreaks.

COVID-19 Sanger Science

The race to sequence SARS-CoV-2

August 19, 2020November 12, 2020 Sanger Institute coronavirus, COVID-19, software developer, software development, technician committment, technicians min read

The Sanger Institute is built for high-throughput science – but the project to sequence coronavirus demanded more samples were handled more quickly than ever before.